Gylcopyrrolate dose in OPC poisoning
Reading File
Searching for glycopyrrolate dosing in organophosphate compound (OPC) poisoning.
search_medical_text
glycopyrrolate dose organophosphate poisoning treatment
Harrison's Principles of Internal Medicine, Twenty First Edition
Page 13018
search_medical_text
anticholinergic therapy OPC poisoning atropine glycopyrrolate
Harrison's Principles of Internal Medicine, Twenty First Edition
Page 13075
GradeResponse
GradeResponse
The retrieved results did not cover glycopyrrolate in OPC poisoning specifically. I'll answer from my own comprehensive knowledge.
Glycopyrrolate in Organophosphate (OPC) Poisoning
Role
Glycopyrrolate is a quaternary ammonium anticholinergic used as an alternative or adjunct to atropine in OPC poisoning. Unlike atropine, it does not cross the blood-brain barrier, so it:
- Controls peripheral muscarinic (respiratory, cardiovascular, GI) effects
- Does not treat central nervous system (CNS) effects (seizures, coma)
Dosing
| Setting | Dose |
|---|---|
| Initial (adult) | 1–2 mg IV |
| Initial (pediatric) | 0.02 mg/kg IV |
| Repeat dosing | Every 5–10 minutes until secretions dry (bronchorrhea resolves) |
| Maintenance infusion | 0.05–0.1 mg/kg/hour IV (once stable) |
The dose of glycopyrrolate required is roughly half that of atropine on a weight basis (glycopyrrolate 1 mg ≈ atropine 2 mg in peripheral anticholinergic effect).
Titration Endpoint
Atropinization endpoints apply equally to glycopyrrolate:
- Drying of bronchial secretions (most important target)
- Heart rate > 80 bpm
- Systolic BP > 80 mmHg
- Cessation of wheeze
Do NOT use pupil dilation or dry skin as endpoints — these are unreliable in OPC poisoning.
Why Glycopyrrolate May Be Preferred Over Atropine
| Feature | Atropine | Glycopyrrolate |
|---|---|---|
| Crosses BBB | Yes | No |
| CNS toxicity (tachycardia, agitation, hyperthermia) | More likely | Much less likely |
| Duration of action | Shorter | Longer (allows less frequent dosing) |
| Onset (IV) | Rapid | Rapid |
Practical Considerations
- Glycopyrrolate is particularly useful when atropine toxicity (central: hyperthermia, agitation, delirium) is a concern despite persistent secretions.
- In massive OPC poisoning, extremely large cumulative doses may be required (hundreds of milligrams of atropine equivalent) — glycopyrrolate reduces CNS adverse effects in this scenario.
- It does not replace oximes (pralidoxime/obidoxime), which reactivate acetylcholinesterase and must be given early.
- Benzodiazepines remain the treatment for OPC-induced seizures (since glycopyrrolate has no CNS penetration).
Summary
Glycopyrrolate 1–2 mg IV (adult) or 0.02 mg/kg IV (pediatric), repeated every 5–10 minutes, titrated to drying of secretions. It is a valuable alternative to atropine with fewer CNS side effects, but will not address central toxicity from OPC poisoning.
This is a shared conversation. Sign in to Orris to start your own chat.